Aspire Biopharma Holdings Inc.(ASBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASBP Aspire Biopharma Holdings Inc.

交易中 04-16 13:43:15 EDT

0.4359

-0.1090

-20.00%

最高0.5735	最低0.4000	成交量828.70万
今开0.5129	昨收0.5449	日振幅31.84%
总市值219.00万	流通市值133.65万	总股本502.41万
成交额398.81万	换手率270.28%	流通股本306.61万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":0.4359,"timestamp":1776361388267,"preClose":0.5449,"halted":0,"volume":8287025,"delay":0,"changeRate":-0.20003670398238216,"floatShares":3066100,"shares":5024142,"eps":-16.375631,"marketStatus":"交易中","change":-0.109,"latestTime":"04-16 13:43:15 EDT","open":0.5129,"high":0.5735,"low":0.4,"amount":3988057.0267275,"amplitude":0.318407,"askPrice":0.4409,"askSize":100,"bidPrice":0.4358,"bidSize":6950,"shortable":0,"etf":0,"ttmEps":-16.375631,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776369600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5449,"preHourTrading":{"tag":"盘前","latestPrice":0.5129,"preClose":0.5449,"latestTime":"09:29 EDT","volume":1072758,"amount":589072.8193221,"timestamp":1776346199999,"change":-0.032,"changeRate":-0.058726,"amplitude":0.293448},"postHourTrading":{"tag":"盘后","latestPrice":0.5499,"preClose":0.5449,"latestTime":"19:59 EDT","volume":196240,"amount":106270.928652,"timestamp":1776297563415,"change":0.005,"changeRate":0.009176,"amplitude":0.084419},"volumeRatio":11.531652},"requestUrl":"/m/hq/s/ASBP/tweets","defaultTab":"tweets","newsList":[{"id":"1108381557","title":"Aspire Biopharma Holdings Inc. 签署意向书 拟收购Dura Driver Control Systems - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1108381557","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108381557?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:35","pubTimestamp":1776342949,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，Aspire Biopharma Holdings Inc. (ASBP) 已就收购Dura Driver Control Systems事宜签署了一份意向书。\n此举标志着这家生物制药公司正积极拓展其业务版图，或将涉足全新的技术领域。意向书的签署通常被视为企业间潜在交易的关键第一步，为后续的尽职调查与最终协议谈判奠定基础。\n市场分析人士将密切关注此交易的后续进展，包括具体的收购条款、资金来源以及对Aspire Biopharma未来发展战略可能产生的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156200842","title":"Aspire Biopharma Holdings Inc. 签署非约束性意向书，拟收购Firefish Topco旗下Driver Controls Systems全部股权——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1156200842","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156200842?lang=zh_cn&edition=full","pubTime":"2026-04-15 18:33","pubTimestamp":1776249227,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会（SEC）的文件，Aspire Biopharma Holdings Inc. 已签署一份非约束性意向书，计划从Firefish Topco公司收购Driver Controls Systems的100%股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185195569","title":"Aspire Biopharma Holdings Inc. 可转换A类优先股对应的普通股最高转售1.59亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1185195569","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185195569?lang=zh_cn&edition=full","pubTime":"2026-02-18 05:22","pubTimestamp":1771363343,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. 宣布，其可转换A类优先股对应的普通股将进行转售，规模最高可达159,090,906股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113073230","title":"Aspire Biopharma Holdings Inc. 提交最多 4150 万股的出售股东增发申请 - SEC 文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1113073230","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113073230?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:06","pubTimestamp":1764760000,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. 提交最多 4150 万股的出售股东增发申请 - SEC 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190289536","title":"Aspire Biopharma Holdings - 根据Eloc协议，公司有权但无义务指示Arena购买最多1亿美元的公司股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1190289536","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190289536?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:05","pubTimestamp":1763125516,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings - 根据Eloc协议，公司有权但无义务指示Arena购买最多1亿美元的公司股票","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169358762","title":"Aspire Biopharma Holdings Inc. - 在11月11日与Arena Business Solutions签署了Eloc协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1169358762","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169358762?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:03","pubTimestamp":1763125428,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. - 在11月11日与Arena Business Solutions签署了Eloc协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511524359","title":"Powerup Acquisition Corp.盘中异动 急速拉升8.65%报13.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524359","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511524359?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:28","pubTimestamp":1739460501,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时28分，Powerup Acquisition Corp.股票出现波动，股价大幅上涨8.65%。截至发稿，该股报13.57美元/股，成交量556股，换手率0.01%，振幅0.00%。Powerup Acquisition Corp.股票所在的壳公司行业中，整体涨幅为0.00%。Powerup Acquisition Corp.公司简介：PowerUp Acquisition Corp 是一家空白支票公司，是为与一个或者多个企业合并、资本证券交易、资产收购、股份收购、重组或者类似的业务合并而形成的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213232821a244b7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213232821a244b7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PWUP","ASBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":-0.5421},{"period":"1month","weight":-0.4411},{"period":"3month","weight":-0.7375},{"period":"6month","weight":-0.96},{"period":"1year","weight":-0.9752},{"period":"ytd","weight":-0.8967}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aspire Biopharma Holdings, Inc.成立于2021年2月9日，是一家特拉华州公司。该公司是一家早期生物制药公司，从事开发和营销新型递送机制颠覆性技术的业务，最初用于“不伤害”药物。迄今为止，Aspire已开发并获得了颠覆性技术，这些技术是一种新型可溶性制剂，旨在解决紧急情况、药物功效、剂量管理和响应时间等问题。Aspire的重点是开发任何数量的可溶性、PH中性、速效粉末或颗粒形式的产品，允许产品的快速舌下吸收。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.11488},{"month":2,"riseRate":0.5,"avgChangeRate":-0.304631},{"month":3,"riseRate":0.25,"avgChangeRate":-0.216086},{"month":4,"riseRate":0.5,"avgChangeRate":-0.182378},{"month":5,"riseRate":0.5,"avgChangeRate":0.002353},{"month":6,"riseRate":0.75,"avgChangeRate":-0.091962},{"month":7,"riseRate":0.75,"avgChangeRate":0.106788},{"month":8,"riseRate":0.75,"avgChangeRate":0.136896},{"month":9,"riseRate":0.5,"avgChangeRate":-0.137877},{"month":10,"riseRate":0.75,"avgChangeRate":0.199866},{"month":11,"riseRate":0.5,"avgChangeRate":-0.177747},{"month":12,"riseRate":1,"avgChangeRate":0.063987}],"exchange":"NASDAQ","name":"Aspire Biopharma Holdings Inc.","nameEN":"Aspire Biopharma Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aspire Biopharma Holdings Inc.(ASBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aspire Biopharma Holdings Inc.(ASBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aspire Biopharma Holdings Inc.,ASBP,Aspire Biopharma Holdings Inc.股票,Aspire Biopharma Holdings Inc.股票老虎,Aspire Biopharma Holdings Inc.股票老虎国际,Aspire Biopharma Holdings Inc.行情,Aspire Biopharma Holdings Inc.股票行情,Aspire Biopharma Holdings Inc.股价,Aspire Biopharma Holdings Inc.股市,Aspire Biopharma Holdings Inc.股票价格,Aspire Biopharma Holdings Inc.股票交易,Aspire Biopharma Holdings Inc.股票购买,Aspire Biopharma Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aspire Biopharma Holdings Inc.(ASBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aspire Biopharma Holdings Inc.(ASBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}